Kaya Holdings (KAYS) Gross Margin Growth (3y) (2017 - 2025)
Kaya Holdings (KAYS) Gross Margin Growth (3y) (2017 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn | 631.00 |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn | 106.00 |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | -675.00 |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn | 33.00 |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn | - |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn | -344.00 |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn | -37,361.00 |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn | 3,557.00 |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn | 622.00 |
| 10 | Kaya Holdings | - | - | 5,370.00 | 3,385.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 3,385.00 |
| Jun 30, 2025 | -3,663.00 |
| Mar 31, 2025 | -3,661.00 |
| Dec 31, 2024 | 145.00 |
| Sep 30, 2024 | 2,001.00 |
| Mar 31, 2024 | -1,588.00 |
| Dec 31, 2023 | -3,003.00 |
| Sep 30, 2023 | 107.00 |
| Jun 30, 2023 | -1,307.00 |
| Mar 31, 2023 | -1,363.00 |
| Dec 31, 2022 | -844.00 |
| Sep 30, 2022 | 1,307.00 |
| Jun 30, 2022 | 715.00 |
| Mar 31, 2022 | 2,130.00 |
| Dec 31, 2021 | 2,039.00 |
| Sep 30, 2021 | 1,585.00 |
| Jun 30, 2021 | 442.00 |
| Mar 31, 2021 | 819.00 |
| Dec 31, 2020 | 315.00 |
| Sep 30, 2020 | -24.00 |